CathWorks’ cover photo
CathWorks

CathWorks

Medical Equipment Manufacturing

Newport Beach, California 12,209 followers

Improving the health of patients by transforming how cardiovascular disease is diagnosed and treated.

About us

CathWorks is a medical technology company focused on applying its advanced computational science platform to optimize Coronary Artery Disease (CAD) therapy decisions and elevate coronary angiography from visual assessment to an objective FFR-based decision-making tool for physicians. FFR-guided PCI decision-making is proven to provide significant clinical benefits for patients with coronary artery disease and economic benefits for patients and payers. Our focus today is specifically on bringing the CathWorks FFRangio™ System to market to provide quick, precise, and objective intraprocedural wire-free FFR guidance that is practical for every case.

Website
http://www.cath.works
Industry
Medical Equipment Manufacturing
Company size
51-200 employees
Headquarters
Newport Beach, California
Type
Privately Held
Founded
2013
Specialties
Medical Device, Artificial Intelligence, Non-invasive, and Cardiovascular

Products

Locations

  • Primary

    4000 MacArthur Blvd

    Suite 1025-East Tower

    Newport Beach, California 92660, US

    Get directions
  • 3 Rapaport

    Kfar Saba, Israel 4465141, IL

    Get directions
  • JR Shinjuku Miraina Tower, 18th fl

    4-1-6 Shinjuku, Shinjuku-ku, Tokyo 160-0022, JP

    Get directions
  • Van Heuven Goedhartlaan 11 A, 6e verdieping

    Amstelveen, 1181LE , NL

    Get directions

Employees at CathWorks

Updates

  • The ALL‑RISE Trial results are in. The ALL‑RISE Trial demonstrated that CathWorks FFRangio: • Delivers similar clinical outcomes to wire-based physiology • Delivers similar safety profile • Improves resource utilization • Reduces procedure time • Optimizes clinical decision-making The new standard of care in coronary physiology. Learn more: https://lnkd.in/gNAXRBWQ #ALLRISE #ANewDawnHasArrived #FFRangio #ProudToBeCathWorks

  • CathWorks reposted this

    As announced at ACC26 — we are thrilled to share results from the ALL-RISE trial! CathWorks #FFRangio met non-inferiority to wire-based physiology for MACE† at one year, with statistically significant improvement in resource utilization and reduced procedure time.¹ These findings affirm CathWorks FFRangio is the new standard in coronary physiology. Learn more and view the benefits and risks. https://lnkd.in/g6p3xajT The information provided by the CathWorks FFRangio®* System is intended to be used by a qualified clinician in conjunction with the patient’s clinical history, symptoms, and other diagnostic tests, as well as the clinician’s professional evaluation. Product usage represented may not be approved for use in all markets.

    • No alternative text description for this image
  • Progress happens because of collaboration. We’re grateful to the investigators, coordinators, and patients across 59 global sites who made the ALL‑RISE Trial possible. Your commitment helped establish a new standard of care in coronary physiology! Learn more about the ALL-RISE Trial results: https://lnkd.in/gNAXRBWQ #ALLRISE #FFRangio #ANewDawnHasArrived 

  • The ALL‑RISE Trial didn’t just measure outcomes - it measured how care is delivered. Compared with pressure‑wire physiology, CathWorks FFRangio reduced radiation exposure, contrast use and procedure time, while delivering similar clinical outcomes. Evidence that efficiency and safety can coexist. Learn more about the ALL-RISE Trial results: https://lnkd.in/gNAXRBWQ #ALLRISE #FFRangio #ANewDawnHasArrived  

  • CathWorks FFRangio demonstrated similar clinical outcomes to pressure wire-guided treatment. CathWorks FFRangio is the only FDA-approved angiography-derived physiology (ADP) technology proven non-inferior to FFR/NHPR in MACE outcomes at one year. Learn more about the ALL-RISE Trial results: https://lnkd.in/gNAXRBWQ Read the full publication in the New England Journal of Medicine: https://lnkd.in/gqZRNF8m #ALLRISE #FFRangio #ANewDawnHasArrived

  • View organization page for CathWorks

    12,209 followers

    Congratulations to Dr. Amit Nanavati, Dr. Dean Abtahi, Dr. Muhammad Khan and Dr. Kizhake Kurian, and the entire team at AdventHealth Palm Coast in Florida for hitting another remarkable milestone - performing over 400 #FFRangio cases! We’re proud to collaborate with teams who are driving a new standard in coronary physiology. To learn more about CathWorks, follow us on LinkedIn. #ProudToBeCathWorks | AdventHealth East Florida Pictured: Doug Elkin, Megan Rockefeller, Connor Fuhrmann, and Lizandra Diaz

    • No alternative text description for this image
  • Not all angiography-derived physiology platforms are the same. CathWorks FFRangio is the only FDA-approved ADP proven non-inferior to FFR & NHPR in MACE outcomes at one year and provides the most comprehensive suite of PCI planning tools. Learn more about the recent ALL-RISE Trial results: https://lnkd.in/gNAXRBWQ #ALLRISE #FFRangio #ProudToBeCathWorks

  • One for the books. We were delighted to host one of our largest and most successful FFRangio Super User Trainings to date, hosting 31 customers from 22 hospitals across the US at the CathWorks HQ for an advanced, hands‑on learning experience. Cath lab professionals from coast to coast joined us for an immersive program focused on deepening clinical expertise and optimizing the integration of CathWorks #FFRangio into everyday practice. We were especially honored to have Dr. Morton Kern a globally respected leader in coronary physiology, share his real‑world insights and clinical perspective - an especially meaningful contribution during a milestone moment for our community. As CathWorks enters this latest chapter, gatherings like this reflect what has always defined us: a deep commitment to clinical partnership, rigorous education, and advancing physiology‑driven care. Thank you to everyone who participated. Your engagement, curiosity, and collaboration made this training truly special… and one we will remember for a long time. #ProudToBeCathWorks

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • Congratulations to the entire team at Norton Healthcare! 👏

    View organization page for Norton Healthcare

    53,455 followers

    Adoption of new technology in cardiovascular care is rarely immediate. Which makes this milestone worth a closer look. At Norton Heart & Vascular Institute, Norton Audubon Hospital ranked #1 in the nation for CathWorks diagnostic imaging use in Q3 2025, just weeks after launching the program in September. What this reflects: - A team willing to adopt and operationalize new technology quickly - Strong alignment between physicians, staff, and leadership - A shared focus on advancing coronary diagnostics and patient care That momentum is already extending beyond our system. We recently hosted a visiting clinician from Medtronic France, with Norton Audubon selected as a training site to support implementation and best practices in Europe.

    • No alternative text description for this image
    • No alternative text description for this image

Similar pages

Browse jobs

Funding

CathWorks 5 total rounds

Last Round

Corporate round

US$ 75.0M

Investors

Medtronic
See more info on crunchbase